Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.
Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page
- ChecktodayChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedSeveral key resources related to rare diseases and clinical trials have been removed, including links to specific disease pages and treatment information, which may impact access to important medical data.SummaryDifference4%
- Check22 days agoChange DetectedNew resources related to rare diseases and specific treatments, including links to Glioblastoma and Glioma information, as well as drug information for Bevacizumab and Pembrolizumab, have been added.SummaryDifference0.4%
- Check29 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference3%
- Check37 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.